ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Pemirolast
  • indication:For the prevention of itching of the eyes caused by allergies such as hay fever, and allergic conjunctivitis
  • pharmacologypharmacology:
  • mechanism: Pemirolast binds to the histamine H<sub>1</sub> receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Pemirolast has also been observed to inhibit antigen-stimulated calcium ion influx into mast cells through the blockage of calcium channels. Pemirolast inhibits the chemotaxis of eosinophils into ocular tissue, and prevents inflammatory mediator release from human eosinophils.
  • toxicity:
  • absorprion:
  • halflife: 4.5 hours (Ophthalmic)
  • roouteelimination: Following topical administration, about 10-15% of the dose was excreted unchanged in the urine.
  • volumedistribution:
  • clearance: